Is There Any Role of Resecting the Stomach to Ameliorate Weight Loss and Sugar Control in Morbidly Obese Diabetic Patients?

被引:17
作者
Frezza, Eldo E. [1 ,2 ]
Wozniak, Susan E. [2 ]
Gee, Laura [2 ]
Wacthel, Mitchell [2 ]
机构
[1] Ctr Metab & Bariatr Dis, Lubbock, TX 79416 USA
[2] Texas Tech Univ Hlth Sci Ctr, Dept Surg, Lubbock, TX USA
关键词
Morbid obesity; Diabetes type II; Metabolic syndrome; Sleeve gastrectomy; LAPAROSCOPIC SLEEVE GASTRECTOMY; BARIATRIC SURGERY; BILIOPANCREATIC DIVERSION; FOOD-INTAKE; GHRELIN; MELLITUS; RISK; THERAPY;
D O I
10.1007/s11695-009-9868-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
Among the restrictive procedures the role of restrictive vs. resecting the stomach is still ambiguous. This study evaluate which is the role of the stomach with respect to blood glucose levels (BG) and percent excess weight loss (EWL) over the 18 months after restrictive procedures in morbid obese diabetic patients. We retrospectively compared a group of patients who underwent partial gastrectomy (just part of the gastric body) with gastric banding (GBSR; n = 27), sleeve gastrectomy (part of gastric body and complete fundus resection; LSG; n = 53) to laparoscopic gastric banding (LAGB; n = 100). Differences among groups at 3, 6, 12, and 18 months were evaluated by analysis of variance. The three cohorts were diabetic patients similar in BMI, age, and gender. At 12 and 18 months, LSG had higher EWL (P < 0.05) and lower BG (P < 0.05) than did either LAGB or GBSR. There were no operative deaths. Complications: LAGB-two staple-line oozing, two wound infections; LSG-one hemorrhage, two staple-line oozing, two leaks; GBSR-one hemorrhage, two wound infections. All complications were readily treated. LSG provides better weight loss and glucose control at 1 year and 1.5 years after surgery than does either LAGB or GBSR, suggesting that gastric fundus resection plays an important, not yet well-defined, role.
引用
收藏
页码:1139 / 1142
页数:4
相关论文
共 39 条
[1]   Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans [J].
Ariyasu, H ;
Takaya, K ;
Tagami, T ;
Ogawa, Y ;
Hosoda, K ;
Akamizu, T ;
Suda, M ;
Koh, T ;
Natsui, K ;
Toyooka, S ;
Shirakami, G ;
Usui, T ;
Shimatsu, A ;
Doi, K ;
Hosoda, H ;
Kojima, M ;
Kangawa, K ;
Nakao, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4753-4758
[2]   Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure [J].
Banks, WA ;
Tschöp, M ;
Robinson, SM ;
Heiman, ML .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (02) :822-827
[3]   Bariatric surgery: A systematic review and meta-analysis [J].
Buchwald, H ;
Avidor, Y ;
Braunwald, E ;
Jensen, MD ;
Pories, W ;
Fahrbach, K ;
Schoelles, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (14) :1724-1737
[4]  
Chan BSW, 2007, INT J CLIN PHARM TH, V45, P455
[5]   Gastric pacing as therapy for morbid obesity: Preliminary results [J].
Cigaina, V .
OBESITY SURGERY, 2002, 12 (Suppl 1) :12S-16S
[6]   Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity [J].
Cottam, D. ;
Qureshi, F. G. ;
Mattar, S. G. ;
Sharma, S. ;
Holover, S. ;
Bonanomi, G. ;
Ramanathan, R. ;
Schauer, P. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2006, 20 (06) :859-863
[7]  
DEITEL M, 2007, OBES SURG, V8, P5
[8]   Adjustable gastric banding and conventional therapy for type 2 diabetes - A randomized controlled trial [J].
Dixon, John B. ;
O'Brien, Paul E. ;
Playfair, Julie ;
Chapman, Leon ;
Schachter, Linda M. ;
Skinner, Stewart ;
Proietto, Joseph ;
Bailey, Michael ;
Anderson, Margaret .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (03) :316-323
[9]   Laparoscopic adjustable gastric band [J].
Fielding, GA ;
Ren, CJ .
SURGICAL CLINICS OF NORTH AMERICA, 2005, 85 (01) :129-+
[10]  
FREZZA EE, 2009, ARCH SURG IN PRESS